Skip to main content Skip to main navigation menu Skip to site footer
Drugs and Therapy Studies

eISSN 2038-9507

  • Archives
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine

    Lisa L. Ross, Marjorie D. Robinson, Giampiero Carosi, Adriano Lazzarin, Hans-Juergen Stellbrink, Graeme Moyle, Naomi Givens, William G. Nichols
    e1
    30-12-2011
    https://doi.org/10.4081/dts.2012.e1
    2262
    PDF: 757
  • Bevacizumab and etoposide combination chemotherapy in patients with recurrent malignant gliomas who failed bevacizumab

    Beverly D. Fu, Mark E. Linskey, Daniela Annenelie Bota
    e6
    24-02-2012
    https://doi.org/10.4081/dts.2012.e6
    1479
    PDF: 713
  • Challenges and limitations of targeting cancer stem cells and/or the tumour microenvironment

    Juan Sebastian Yakisich
    e10
    10-05-2012
    https://doi.org/10.4081/dts.2012.e10
    4871
    PDF: 1252
1 - 3 of 3 items

  • Bevacizumab and etoposide combination chemotherapy in patients with recurrent malignant gliomas who failed bevacizumab
    61
  • Development of a drug safety ePlatform for physicians, pharmacists, and consumers based on post-marketing adverse events
    10
  • Self-reported adverse reactions associated with topical ophthalmic medication use: a cross-sectional survey
    9
  • C11 cyclopentenone from the ascidian Diplosoma sp. prevents epidermal growth factor-induced transformation of JB6 cells
    9
  • Formulation, development and evaluation of injectable formulation of Aspirin
    7

Keywords

Analytics

Analytics

Drugs and Therapy Studies

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 2038-9493
eISSN: 2038-9507

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.